Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage: The Ibaraki Prefectural Health Study

Background— Few studies have examined the association between low levels of low-density lipoprotein (LDL) cholesterol and risk of intraparenchymal hemorrhage. Methods and Results— A total of 30 802 men and 60 417 women, 40 to 79 years of age with no history of stroke or coronary heart disease, completed a baseline risk factor survey in 1993 under the auspices of the Ibaraki Prefectural Health Study. Systematic mortality surveillance was performed through 2003, and 264 intraparenchymal hemorrhage deaths were identified. LDL cholesterol levels were calculated with the Friedewald formula. Persons with LDL cholesterol ≥140 mg/dL had half the sex- and age-adjusted risk of death due to intraparenchymal hemorrhage of those with LDL cholesterol <80 mg/dL. After adjustment for cardiovascular risk factors, the multivariable hazard ratio compared with persons with LDL cholesterol <80 mg/dL was 0.65 (95% CI 0.44 to 0.96) for those with LDL cholesterol 80 to 99 mg/dL, 0.48 (0.32 to 0.71) for 100 to 119 mg/dL, 0.50 (0.33 to 0.75) for 120 to 139 mg/dL, and 0.45 (0.30 to 0.69) for ≥140 mg/dL. These inverse associations were not altered substantially after the exclusion of persons with hypertriglyceridemia, after analysis with a Cox proportional hazard model with time-dependent covariates, or in sensitivity analysis for the potential effect of competing risks. Conclusions— Low LDL cholesterol levels are associated with elevated risk of death due to intraparenchymal hemorrhage.

[1]  D. Lanska Adams and Victor’s Principles of Neurology , 2010 .

[2]  H. Iso,et al.  Letter by Noda and Iso regarding article, "Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study". , 2009, Circulation.

[3]  P. Amarenco,et al.  Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.

[4]  L. Goldstein The complex relationship between cholesterol and brain hemorrhage. , 2009, Circulation.

[5]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[6]  L. Caplan Cerebrovascular diseases. , 2008, Reviews in neurological diseases.

[7]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[8]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[9]  D. Lawlor,et al.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.

[10]  A. Chiloeches,et al.  RhoA and p38 MAPK mediate apoptosis induced by cellular cholesterol depletion , 2006, Apoptosis.

[11]  F. Irie,et al.  The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. , 2006, Kidney international.

[12]  Michael Höfler,et al.  The Bradford Hill considerations on causality: a counterfactual perspective , 2005, Emerging themes in epidemiology.

[13]  T. Lumley,et al.  The Association Between Lipid Levels and the Risks of Incident Myocardial Infarction, Stroke, and Total Mortality: The Cardiovascular Health Study , 2004, Journal of the American Geriatrics Society.

[14]  P. Couture,et al.  Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. , 2004, Clinical biochemistry.

[15]  曲东锋 Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[16]  Y. Yoshida,et al.  An electron microscopic study of plasmatic arterionecrosis in the human cerebral arteries , 1976, Virchows Archiv A.

[17]  Y. Yoshida,et al.  Morphogenesis of plasmatic arterionecrosis as the cause of hypertensive intracerebral hemorrhage , 1973, Virchows Archiv A.

[18]  Shinichi Sato,et al.  Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. , 2003, Journal of atherosclerosis and thrombosis.

[19]  H. Iso,et al.  Fat and protein intakes and risk of intraparenchymal hemorrhage among middle-aged Japanese. , 2003, American journal of epidemiology.

[20]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[21]  J. Roh,et al.  Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions , 2002, Stroke.

[22]  J. Roh,et al.  Gradient echo magnetic resonance imaging in the prediction of hemorrhagic vs ischemic stroke: a need for the consideration of the extent of leukoariosis. , 2002, Archives of neurology.

[23]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[24]  L. Appel,et al.  Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study , 2001, The Lancet.

[25]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[26]  J. Manson,et al.  Application of computer tomography-oriented criteria for stroke subtype classification in a prospective study. , 2000, Annals of epidemiology.

[27]  D. Albanes,et al.  Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. , 1999, Stroke.

[28]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[29]  K. Iseki,et al.  Low serum cholesterol as a risk factor for hemorrhagic stroke in men: a community-based mass screening in Okinawa, Japan. , 1999, Japanese circulation journal.

[30]  D. Jacobs,et al.  Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. , 1996, Stroke.

[31]  D. Reed,et al.  Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men. , 1995, JAMA.

[32]  M Lunn,et al.  Applying Cox regression to competing risks. , 1995, Biometrics.

[33]  D. Atsma,et al.  The effect of sarcolemmal cholesterol content on the tolerance to anoxia in cardiomyocyte cultures. , 1994, Journal of molecular and cellular cardiology.

[34]  M. Law,et al.  Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study , 1994, BMJ.

[35]  N J Wald,et al.  By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? , 1994, BMJ.

[36]  L. Råstam,et al.  Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. , 1993, Annals of epidemiology.

[37]  D. Jacobs,et al.  Associations of Serum Total Cholesterol, Different Types of Stroke, and Stenosis Distribution of Cerebral Arteries: The Akita Pathology Study , 1993, Stroke.

[38]  D. Jacobs,et al.  Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .

[39]  H. Iso,et al.  [A population-based study of the proportion by type of stroke determined by computed tomography scan]. , 1991, [Nihon koshu eisei zasshi] Japanese journal of public health.

[40]  R. Saracci,et al.  International Guidelines for Ethical Review of Epidemiological Studies , 1991, Law, medicine & health care : a publication of the American Society of Law & Medicine.

[41]  M. Iida,et al.  Prognosis and disability of stroke patients after 5 years in Akita, Japan. , 1990, Stroke.

[42]  D. Reed,et al.  Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. , 1989, Stroke.

[43]  D. Jacobs,et al.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. , 1989, The New England journal of medicine.

[44]  H. Iso,et al.  Trends for coronary heart disease and stroke and their risk factors in Japan. , 1989, Circulation.

[45]  T. Omae,et al.  Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. , 1988, Stroke.

[46]  H. Kato,et al.  Cerebrovascular Diseases in a Fixed Population of 653 Hiroshima and Nagasaki, With Special Reference to Relationship Between Type and Risk Factors , 1984, Stroke.

[47]  C. Date,et al.  Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. , 1982, Stroke.

[48]  H. Ueshima,et al.  Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. , 1980, Preventive medicine.

[49]  J. Popper,et al.  Factors Related to Stroke Incidence in Hawaii Japanese Men: The Honolulu Heart Study , 1980, Stroke.

[50]  N. Hayakawa,et al.  A Prospective Study of Cerebrovascular Disease in Japanese Rural Communities, Akabane and Asahi: Part 1 Evaluation of Risk Factors in the Occurrence of Cerebral Hemorrhage and Thrombosis , 1976, Stroke.

[51]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.